Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes (一项为期54周的对持续使用二甲双胍与罗格列酮联合治疗的2型糖尿病患者加用西格列汀治疗的有效性与安全性的随机安慰剂对照研究)*-Reference-Cited by-同舟云学术

Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes (一项为期54周的对持续使用二甲双胍与罗格列酮联合治疗的2型糖尿病患者加用西格列汀治疗的有效性与安全性的随机安慰剂对照研究)*

Published:2013-02-05 Issue:1 Volume:5 Page:68-79
ISSN:1753-0393
Container-title:Journal of Diabetes
language:en
Short-container-title:J Diabetes

Author:

DOBS Adrian S.,GOLDSTEIN Barry J.,ASCHNER Pablo,HORTON Edward S.,UMPIERREZ Guillermo E.,DURAN Lorraine,HILL Julie S.,CHEN Yu,GOLM Gregory T.,LANGDON Ronald B.,WILLIAMS-HERMAN Debora E.,KAUFMAN Keith D.,AMATRUDA John M.,FERREIRA Juan Camilo ARJONA

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1753-0407.2012.00223.x/fullpdf

Reference36 articles.

1. Triple oral antidiabetic therapy in type 2 diabetes mellitus;Ovalle;Endocr Pract,1998

2. Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients;Rosenstock;Diabetes Care,2006

3. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

4. Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study-II);Bell;Diabetes Obes Metab,2011

5. Hypoglycemia: Still the limiting factor in the glycemic management of diabetes;Cryer;Endocr Pract,2008

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Green and eco‐friendly biosynthesis of zinc oxide nanoparticles using Calendula officinalis flower extract: Wound healing potential and antioxidant activity;International Wound Journal;2023-09-18

2. Type 2 diabetics followed up by family physicians: Treatment sequences and changes over time in weight and glycated hemoglobin;Primary Care Diabetes;2022-10

3. Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials;BMJ;2022-06-28

4. Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus;BMC Medicine;2020-11-16

5. Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus;Bioscience Reports;2019-07